iFIT Cluster of Excellence Newsletter Vol. IV
|
|
|
Dear members, With our Email Newsletter, we want to keep you up to date with all new information surrounding our “Image-Guided and Functionally Instructed Tumor Therapies” Cluster of Excellence. Vol. IV includes news, publications and general information from the past three months. The next newsletter will be published on March 1, 2024.
We wish you all a Merry Christmas and a Happy New Year and are already looking forward to working with you together in 2024! If you have any comments or feedback feel free to get in touch with us: ifitoffice@med.uni-tuebingen.de With best regards, iFIT Office Team |
|
|
| Visit of Rector of USP Sao Paulo, Brazil |
|
|
| Dr. Lukas Mager receives ERC Starting Grant
|
|
|
| Farewell Symposium of Prof. Hans-Georg Rammensee
|
|
|
| How the innate immune system helps fight corona in young children |
|
|
| Women in Science Symposium
|
|
|
| Art meets Science! iFIT Visualization Award
|
|
|
| Annual Strategy Retreat & SAB Meeting in Schluchsee |
|
|
| We were part of the Science & Innovation Days 2023
|
|
|
| Dr. Florian Wimmers receives Robert Koch Postdoctoral Award 2023
|
|
|
| Science Fair: Virtual Reality meets Cancer Research
|
|
|
| iFIT Merry Science
13th of December 2023 at 05:00pm (CET)
iFIT Building, Röntgenweg 11
|
|
|
| iFIT Seminar Series with Dr. Steve Pascolo
15th of January 2024 at 12:00pm (CET)
Medical Clinic Big Lecture Hall, Otfried-Müller-Str. 10
|
|
|
| iFIT Workshop: Unconscious Bias with Dr. Dorothee Kaiser
18th of January 2024 from 09:00am - 05:00pm (CET)
iFIT Seminar Room, Röntgenweg 11
|
|
|
| iFIT Workshop: Grant Writing with Dr. Christina Schütte
23rd to 24th of January 2024 from 09:00am - 05:30pm
iFIT Seminar Room, Röntgenweg 11
|
|
|
| iFIT Workshop: Intercultural Diversity at University with Dr. Dorothee Kaiser
26th of February 2024 from 09:00am - 05:00pm
iFIT Seminar Room, Röntgenweg 11
|
|
|
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth |
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease |
Heitmann, J. Schlenk, R. et al. Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease. J Hematol Oncol. 17, 16(1):96 (2023). https://doi.org/10.1186/s13045-023-01490-w IF: 23.1 |
DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts |
Goyal, A., Bauer, J., Hey, J. et al. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts. Nat Commun 14, 6731 (2023). https://doi.org/10.1038/s41467-023-42417-w IF: 16.6 |
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification |
Hoenisch Gravel, N., Nelde, A., Bauer, J. et al. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification. Nat Commun 14, 7472 (2023). https://doi.org/10.1038/s41467-023-42692-7 IF: 16.6
|
Translating genomic tools to Raman spectroscopy analysis enables high-dimensional tissue characterization on molecular resolution |
Sigle, M., Rohlfing, AK., Kenny, M. et al. Translating genomic tools to Raman spectroscopy analysis enables high-dimensional tissue characterization on molecular resolution. Nat Commun 14, 5799 (2023). https://doi.org/10.1038/s41467-023-41417-0 IF: 16.6
|
Young oncologists' perspective on the role and future of the clinician-scientist in oncology |
Lim, K., Westphalen, C. [...] Amaral, T. Young oncologists' perspective on the role and future of the clinician-scientist in oncology. ESMO Open. 2023 Oct;8(5):101625. doi: 10.1016/j.esmoop.2023.101625. IF: 7.3
|
|
|
Follow us on social media
|
Legal Notice
Cluster of Excellence “Image-Guided and Functionally Instructed Tumor Therapies” (iFIT)
Röntgenweg 11
72076 Tübingen, Germany Contact:
Public Relations
Steven Pohl Mail: steven.patrick.pohl@med.uni-tuebingen.de Click here to unsubscribe
|
|
| |
